8 results on '"S. Ogura"'
Search Results
2. Cigarette Smoking Cessation Temporarily Enhances the Release of Phosphorylated-HSP27 from Human Platelets.
- Author
-
Onuma T, Iida M, Kito Y, Tanabe K, Kojima A, Nagase K, Uematsu K, Enomoto Y, Doi T, Tokuda H, Ogura S, Iwama T, Kozawa O, and Iida H
- Subjects
- Collagen pharmacology, Humans, Blood Platelets metabolism, HSP27 Heat-Shock Proteins metabolism, Phosphorylation physiology, Smoking Cessation, Tobacco Smoking physiopathology
- Abstract
Objective Cigarette smoking is a risk factor for arteriopathy, including acute coronary syndrome, stroke and peripheral vascular disease. Thus, cessation is strongly recommended in order to reduce these risks. We recently demonstrated that smoking cessation causes temporary hyper-aggregability of human platelets. We previously showed that heat shock protein 27 (HSP27) is released from human platelets stimulated by collagen, accompanied by its phosphorylation. Accumulating evidence indicates potent roles of extracellular HSP27 as a modulator of inflammation. In the present study, using the stored samples obtained in the previous study, we investigated the effect of cigarette smoking cessation on the release of phosphorylated-HSP27 from collagen-activated human platelets (n=15 patients). Methods We enrolled patients who visited smoking cessation outpatient services between January 2012 and November 2014. Platelet-rich plasma, chronologically obtained before and after the cessation, was stimulated by collagen using a PA-200 aggregometer in the previous study. The levels of phosphorylated-HSP27 released from platelets were determined by an enzyme-linked immunosorbent assay. The phosphorylation of HSP27 in platelets was evaluated by a Western blot analysis. Results Cessation of cigarette smoking significantly upregulated the levels of collagen-stimulated release of phosphorylated-HSP27 at four and eight weeks after quitting smoking compared to before cessation. However, there was no significant difference between the levels before cessation and those at 12 weeks after cessation. The levels of phosphorylated-HSP27 stimulated by collagen in the platelets at four weeks after smoking cessation were remarkably enhanced compared to before cessation. Conclusion Cigarette smoking cessation temporarily enhances the collagen-stimulated release of phosphorylated-HSP27 from human platelets in the short term.
- Published
- 2020
- Full Text
- View/download PDF
3. Primary IgA Vasculitis with Nephritis in a Patient with Rheumatoid Arthritis Diagnosed by Anti-galactose-deficient IgA1 Immunostaining.
- Author
-
Karasawa K, Iwabuchi Y, Kyoda M, Akihisa T, Yamaguchi E, Suzuki S, Ogura S, Takabe T, Miyabe Y, Kamiyama T, Nakano M, Manabe S, Kamiyama M, Akiyama K, Sato M, Uchida K, Nitta K, and Moriyama T
- Subjects
- Antirheumatic Agents therapeutic use, Arthritis, Rheumatoid drug therapy, Etanercept therapeutic use, Female, Galactose immunology, Glomerulonephritis, IGA etiology, Glomerulonephritis, IGA immunology, Humans, IgA Vasculitis etiology, IgA Vasculitis immunology, Middle Aged, Arthritis, Rheumatoid complications, Glomerulonephritis, IGA diagnosis, IgA Vasculitis diagnosis, Immunoglobulin A analysis
- Abstract
Renal disease is a common complication of rheumatoid arthritis (RA) and can occur secondary to RA or be induced by therapeutic agents. Recently, glomerular deposition of galactose-deficient IgA1 (Gd-IgA1) was identified as a feature of primary IgA vasculitis with nephritis (IgA-VN). We herein report a case of IgA-VN in an RA patient whose disease activity was controlled by treatment with etanercept. To distinguish between primary IgA-VN and secondary IgA-VN caused by RA or etanercept, we performed immunostaining of renal biopsy sections with the Gd-IgA1-specific antibody KM55. Positive KM55 staining confirmed the diagnosis of primary IgA-VN in a patient with RA.
- Published
- 2019
- Full Text
- View/download PDF
4. Pulmonary tuberculoma in a patient with chronic hepatitis C: a clinical pitfall in the treatment strategy.
- Author
-
Saitou Y, Hatazi O, Aonuma H, Ogura S, Yamamoto N, and Kobayashi T
- Subjects
- DNA, Viral analysis, Drug Therapy, Combination, Female, Follow-Up Studies, Hepacivirus genetics, Hepatitis C, Chronic complications, Humans, Image-Guided Biopsy, Isoniazid therapeutic use, Lung diagnostic imaging, Lung microbiology, Lung pathology, Middle Aged, Mycobacterium tuberculosis isolation & purification, Practice Guidelines as Topic, Pyrazinamide therapeutic use, Rifampin therapeutic use, Tomography, X-Ray Computed, Tuberculoma complications, Tuberculoma diagnosis, Tuberculosis, Pulmonary complications, Tuberculosis, Pulmonary diagnosis, Antitubercular Agents therapeutic use, Antiviral Agents therapeutic use, Hepatitis C, Chronic drug therapy, Tuberculoma drug therapy, Tuberculosis, Pulmonary drug therapy
- Abstract
We herein report a clinical pitfall regarding the treatment of a case of pulmonary tuberculoma in a patient with chronic hepatitis C. The patient presented with both chronic hepatitis C and pulmonary tuberculoma, and we initiated treatment of the chronic hepatitis C first due to the potential for liver injury; however, the patient's condition worsened in terms of the pulmonary tuberculosis. This case highlights the need to select the initial treatment for pulmonary tuberculoma, not chronic hepatitis C. In addition, we report that, although the administration of anti-tuberculosis chemotherapy regimens containing pyrazinamide (PZA) substantially increases the incidence of drug-induced hepatitis in patients with chronic hepatitis, we were fortunately able to use PZA without observing drug-induced hepatitis in this case because we closely monitored the patient's liver function.
- Published
- 2014
- Full Text
- View/download PDF
5. Sarcomatous hepatocellular carcinoma with remittent fever.
- Author
-
Inagaki Y, Sugimoto K, Shiraki K, Yoshizawa N, Tameda M, Ogura S, Yoneda M, Takei Y, Fuke H, Hashimoto A, Yamamoto N, and Shimizu A
- Subjects
- Aged, C-Reactive Protein metabolism, Carcinoma, Hepatocellular blood, Carcinoma, Hepatocellular diagnosis, Diagnostic Errors, Humans, Liver Abscess diagnosis, Liver Neoplasms blood, Liver Neoplasms diagnosis, Male, Sarcoma blood, Sarcoma diagnosis, Carcinoma, Hepatocellular complications, Fever etiology, Liver Neoplasms complications, Sarcoma complications
- Abstract
We herein report a rare case of hepatocellular carcinoma (HCC) with sarcomatous changes. A 66-year-old man was admitted to our hospital with a high fever and upper abdominal pain. Initially, he was diagnosed as having a liver abscess; however, antibiotic treatment and drainage were ineffective. Further imaging studies revealed the typical appearance of HCC: the tumor had invaded the hepatic and portal veins. Surgical resection of the tumor was performed. A pathological examination demonstrated the presence of a sarcomatous hepatocellular carcinoma. Sarcomatous hepatocellular carcinoma with remittent fever is a rare disease entity.
- Published
- 2012
- Full Text
- View/download PDF
6. Effects of an antithrombin drug in patients with subacute exacerbations of Binswanger disease.
- Author
-
Tomimoto H, Akiguchi I, Ohtani R, Yagi H, Ogura S, and Wakita H
- Subjects
- Acute Disease, Aged, Arginine analogs & derivatives, Female, Humans, Male, Middle Aged, Sulfonamides, Antithrombins therapeutic use, Dementia, Vascular drug therapy, Pipecolic Acids therapeutic use
- Abstract
The blood coagulation system has been shown to be activated in subacute exacerbations of Binswanger disease (BD). In our previous study, the antithrombin drug argatroban t ameliorated the neurological exacerbations in a BD patient with antiphospholipid antibody syndrome. We have further examined the therapeutic efficacy of argatroban in 3 BD patients with subacute exacerbations, but without any immune-mediated prothrombotic complications. In 1 out of these 4 patients, treatment with sodium ozagrel, an antiplatelet drug was applied, but was ineffective. In all patients, argatroban treatment reduced the levels of the hemostatic markers, with a corresponding improvement in cognitive dysfunction and gait disorders. These results suggest that the antithrombin effect is true also for BD patients not compromised by the immune-mediated prothrombotic condition.
- Published
- 2000
- Full Text
- View/download PDF
7. Mucous gland adenoma of the trachea resected with an endoscopic neodymium: yttrium aluminum garnet laser.
- Author
-
Ishida T, Kamachi M, Hanada T, Yamazaki K, Ogura S, Isobe H, and Kawakami Y
- Subjects
- Aged, Bronchoscopy, Cystadenoma diagnostic imaging, Cystadenoma pathology, Humans, Male, Tomography, X-Ray Computed, Tracheal Neoplasms diagnostic imaging, Tracheal Neoplasms pathology, Cystadenoma surgery, Endoscopy, Laser Therapy methods, Tracheal Neoplasms surgery
- Abstract
We report a case of mucous gland adenoma of the trachea in a 73-year-old male revealed by bronchoscopy. The tumor was resected with a contact neodymium: yttrium aluminum garnet (Nd-YAG) laser after five years of observation. The tumor was histologically peculiar because it presented numerous cystically dilated, or irregularly shaped mucus-filled glands lined with cuboidal or tall columnar cells. In some parts, the lining cells of the tumor showed papillary proliferation. We diagnosed this tumor as a mucous gland adenoma of the trachea. We review the clinical features of this rare tumor and discuss the usefulness of the laser in the diagnosis and the therapy.
- Published
- 1996
- Full Text
- View/download PDF
8. "Web-like obstruction"--a sign of regional complete remission after concurrent chemoradiotherapy in small cell lung cancer.
- Author
-
Hanada T, Ogura S, Isobe H, Dosaka-Akita H, Yamazaki K, Watanabe N, and Kawakami Y
- Subjects
- Aged, Bronchoscopy, Carcinoma, Small Cell drug therapy, Carcinoma, Small Cell pathology, Carcinoma, Small Cell radiotherapy, Combined Modality Therapy, Humans, Lung Neoplasms drug therapy, Lung Neoplasms pathology, Lung Neoplasms radiotherapy, Male, Remission Induction, Antineoplastic Agents therapeutic use, Bronchi pathology, Carcinoma, Small Cell therapy, Lung Neoplasms therapy
- Abstract
Two patients with small cell lung cancer (SCLC) developed "web-like" mucosa that obstructed bronchi after concurrent chemoradiotherapy. It seemed that the orifice of the bronchi had disappeared. Since the patients were free of local recurrence and the histologic findings of "web-like" mucosa were negative for malignancy, we believe that "web-like obstruction" was additional sign of regional complete remission of SCLC after concurrent chemoradiotherapy.
- Published
- 1996
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.